Galectin Therapeutics Inc (GALTU.OQ)

GALTU.OQ on NASDAQ Stock Exchange Capital Market

5.32USD
18 Sep 2012
Price Change (% chg)

$-1.13 (-17.52%)
Prev Close
$6.50
Open
$5.32
Day's High
$5.32
Day's Low
$5.32
Volume
300
Avg. Vol
109
52-wk High
$59.50
52-wk Low
$11.35

GALTU.OQ

Chart for GALTU.OQ

About

Galectin Therapeutics Inc., formerly Pro-Pharmaceuticals, Inc. is a development-stage company. The Company is engaged in drug development to create therapies for cancer and fibrotic disease. As of December 31, 2011, the Company has two compounds in development, one is to be used in cancer therapy and the other intended to be... (more)

Overall

Beta: 1.64
Market Cap (Mil.): $116.16
Shares Outstanding (Mil.): 22.00
Dividend: --
Yield (%): --

Financials

  GALTU.OQ Industry Sector
P/E (TTM): -- 144.58 33.70
EPS (TTM): -0.83 -- --
ROI: -82.26 -2.25 17.35
ROE: -149.03 -6.85 18.21
Search Stocks

Competitors

  Price Change
Novartis AG (NOVN.VX) CHF88.45 +0.15
Merck & Co., Inc. (MRK.N) $60.49 +0.18
Roche Holding Ltd. (ROG.VX) CHF282.40 -0.80
Eli Lilly and Co (LLY.N) $66.53 -0.06
Momenta Pharmaceuticals, Inc. (MNTA.OQ) $11.52 -0.08

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: ValuEngine, Inc.
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks